Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Need PR coverage on Patient- 21 months insulin independent

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Jan 10, 2022 1:17pm

294 Views

Post# 34300417

Need PR coverage on Patient- 21 months insulin independent

Just emailed Dr T to remind him to ensure we get coverage on CTV with
Avis Favaro, she is highly respected in the Health field and to ensure
someone contact Gina Kolata, NY Times as we have a much better story
for her than Semma gave her. We need the IR Team letting the Press know
we have World Class News. Hopefully, they had the NR's circulating this morning.

If we can get good Press Coverage and get the stock back up, the Devils
have to cover their shorts. Time to play hardball with them.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)